A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) — Stella

Recruiting

Back to Advanced Liver Cancers trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

Shanghai Tenth People's Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Very early testing

Sponsor

Shanghai Juncell Therapeutics

Collaborators

Shanghai 10th People's Hospital

Enrollment target

~50 participants

Started

September 2021

Primary completion

September 2026

Age range

18 Years – 75 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov